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Osteoporosis Canada’s 2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada focus on the
clinical impact of fragility fractures, and on the assessment and management of women and men at high risk for fragility fracture. These
guidelines now integrate a 10-year absolute fracture risk prediction into an overall management approach by using validated risk assessment
tools. There currently is a large gap between optimal practices and those that are now being provided to Canadians with osteoporosis. These
guidelines are part of a concerted effort to close this gap. Key changes from the 2002 guidelines of interest and relevance to radiologists are
highlighted in this report.
 2011 Canadian Association of Radiologists. All rights reserved.
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rosis has evolved. Because the disease typically causes
symptoms only when fractures result, the diagnosis tended,
in the past, to be made late. The development of tools to
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doi:10.1016/j.carj.2011.05.001central skeleton, has allowed identification of individuals at
high risk of fragility fracture before the first fracture.
A landmark was the publication of a diagnostic classifi-
cation by a working group of the World Health Organization
(WHO) in 1994 [1]. This defined osteoporosis in a post-
menopausal woman as a BMD of 2.5 or more standard
deviations (SD) below a young adult norm, that is, a T score
of e2.5 or lower. This value roughly corresponded with the
fraction of the population sustaining fragility fractures,ll rights reserved.
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women with a T score this low. However, this became widely
accepted as a BMD-derived definition of osteoporosis, was
commonly used as a treatment threshold, and is now also
applied to men older than age 50 years (Table 1) [2,3].
However, the WHO classification, despite its merits,
proved to be limiting for a number of reasons, not the least of
which was that it placed undue emphasis on the importance
of BMD as a risk factor for osteoporotic fractures while
obscuring the complexity of fracture risk, which is due to
many factors.The 2010 Osteoporosis Canada Clinical Practice
Guidelines
The development of these guidelines followed the
Appraisal of Guidelines, Research and Evaluation frame-
work [4]. Primary care physicians, patients, osteoporosis
specialists from different disciplines, radiologists, allied
health professionals, and health policy makers were surveyed
to identify priorities for the guidelines. Based on these,
systematic reviews of the literature were conducted to update
our knowledge in 2 key areas: (1) fracture risk assessment
and (2) therapies for osteoporosis. Also, Canadian data are
now available to inform many of these recommendations.Table 1
Recommended diagnostic categories for both men and women based on
bone densitometry
Age Category Criteriaa
<50 y Below expected range for age Z score e2.0
Within expected range for age Z score >e2.0
50 y Severe (established) osteoporosis T score e2.5
with fragility fractures
Osteoporosis T score e2.5
Low bone mass T score ¼e1.1 and e2.4
Normal T score e1.0
BMD ¼ bone mineral density.
aNotes:
1) The T score is the number of standard deviations that BMD is above or
below the mean normal peak BMD for young white women (the National
Health and Nutrition Education Survey III for hip measurements).
The Z score is the number of standard deviations that BMD above or
below the mean normal BMD for sex, age, and (if reference data are
available) race or ethnicity.
2) Osteoporosis cannot be diagnosed by BMD alone below age 50 y.
3) Based upon lowest value for lumbar spine (minimum 2 vertebral levels),
total hip, and femoral neck. If either the lumbar spine or hip is invalid,
then the forearm should be scanned and the distal third of the region
reported.
4) Fracture risk assessment under the Fracture Risk Assessment Tool / 2010
Canadian Association of Radiologists and Osteoporosis Canada system is
based upon the femoral neck T score alone.Appropriate interventions to prevent fractures need
to accurately identify those at risk and, therefore, most likely
to benefit from treatment [5]. Unfortunately, many of those
who sustain a fragility fracture are neither appropriately
assessed nor treated [6,7]. The 2010 guidelines focus on the
assessment and management of women and men at high risk
for such a fracture [7]. Low BMD is only one of several risk
factors for fracture, and, in recognition of this, Osteoporosis
Canada (OC) and the Canadian Association of Radiologists
(CAR) adopted a system for 10-year absolute fracture risk
assessment to be used in BMD reporting [8]. The 2010
guidelines have updated this absolute risk assessment model
and developed recommendations for comprehensive care
(Figure 1).Key ConceptsThe 2010 guidelines use an integrated risk assessment
(based on BMD and other risk factors) and treatment model
to stratify women and men older than age 50 years into 3
fracture risk groups. These categories align with treatment
implications: low risk (usually not requiring pharmacologic
treatment), moderate risk (consider additional clinical risk
factors to determine any need for pharmacologic treatment),
and high risk (should be considered for pharmacologic
treatment) [7]. Nonpharmacologic and lifestyle measures are
applicable to all: optimizing calcium and vitamin D intake,
regular weight-bearing activity, balance and strengthening
exercises, and smoking cessation. In older patients, fall
prevention should be considered, including a multifactorial
assessment of causes contributing to risk.
These categories are defined as follows:
 High risk for future fractures. Implied is a >20% prob-
ability of major osteoporotic fracture (ie, proximal
femoral, clinical vertebral, forearm, or proximal humeral
break) over the ensuing 10 years. Individuals older than
age 50 years who have had a fragility fracture of the hip
or vertebra and those who have had more than 1 fragility
fracture are also considered to be high risk for future
fractures, irrespective of BMD [9e12]. Pharmacologic
therapy should be offered to these individuals.
 Moderate risk for future fractures. Implied is 10%-20%
probability for major osteoporotic fracture over 10 years.
For those at moderate fracture risk with no other risk
factors, treatment should be individualized and may
include pharmacologic therapy, or just basic lifestyle
measures with monitoring. There are more osteoporotic
fractures in the moderate fracture risk group than in the
high fracture risk group (because there are more indi-
viduals at moderate risk than at high risk), even though
the individual fracture risk is higher in the high-risk
group [13]. The moderate-risk group requires a careful
evaluation to identify vertebral fractures (Table 2) or
additional clinical risk factors (Figure 1), which may
contribute to a decision to offer pharmacologic therapy.
Figure 1. An integrated approach to management of patients who are at risk for fracture. Dashed arrow indicates that evidence for benefit from pharmaco-
therapy is not as strong in this instance as for other recommendations. BMD ¼ bone mineral density. Reprinted from Papaioannou et al [7] with permission
from CMAJ.  2010 Canadian Medical Association.
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Table 2
Key points on vertebral fracture recognition and radiologist reporting
 Physicians should be aware of the importance of vertebral fracture
diagnosis in assessing future osteoporotic fracture risk.
 Vertebral compression fractures incidental to radiologic examinations done
for other reasons should be identified and reported.
 Vertebral fractures should be assessed from lateral spinal or chest
radiographs according to the semiquantitative method of Genant et al [17];
grade II (26%-40%) and grade III (>40%) fractures as classified by this
method should be given the greatest emphasis.
 Semiquantitative fracture diagnosis should include the recognition of
changes such as loss of vertebral end-plate parallelism, end-plate
interruptions, cortical buckling, and quantitative changes in the anterior,
mid body, and posterior heights of vertebral bodies.
When spine radiographs are performed to assess the presence of vertebral
fractures, anteroposterior examinations may assist in the initial evaluation.
 The standard follow-up need only consist of single lateral views of the
thoracic and lumbar spine that include T4-L4 vertebrae.
 Dual-energy x-ray absorptiometry examinations that include lateral spinal
morphologic assessments (vertebral fracture assessment) may contribute
to fracture recognition.
 Educational material about the clinical importance of vertebral fracture
recognition as a potential indicator of future osteoporotic fracture risk
with its associated morbidity and mortality should be directed to all
physicians.
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bility for major osteoporotic fracture over 10 years.
These individuals usually do not require pharmacologic
therapy. In general, the lifestyle measures referred to
earlier are sufficient for those at low fracture risk who do
not have additional risk factors for rapid BMD loss.Fracture Risk Assessment and the Importance of
Radiologic InvestigationsThe term ‘‘osteopenia’’ has been replaced by ‘‘low bone
mass’’ in the WHO classification. It is recommended that
radiologists reclaim osteopenia as the term to describe low
bone mass seen on plain radiographs or computed tomog-
raphy recognizing the subjectivity of the observation and its
dependance on technical factors in making the image.
Vertebral fractures are strongly associated with future
osteoporotic fractures independent of prior clinical fracture
history [10,12,14]. The 2010 OC Guidelines emphasize the
potential for a change in height measurement to detect
vertebral fractures. When accurately measured, height loss
that exceeds 2 cm in less than 3 years may indicate the
presence of such a fracture and when observed should be
investigated by means of a lateral thoracic and lumbar spine
radiograph [15]. Vertebral fracture is the most common
manifestation of osteoporosis. However, about two-thirds of
these fractures are asymptomatic or present with symptoms
that do not lead to a diagnosis [14]. In the Canadian Multi-
centre Osteoporosis Study (CaMos), radiographic fractures
were associated with an increased risk of future fractures
independent of clinical fracture and have been found to affect
quality of life [6].
Osteoporotic vertebral fractures are best defined on lateral
radiographs as 25% or greater height loss of the anterior, mid,or posterior vertical dimensions of an individual vertebra,
especially if there is end-plate disruption [16]. Mild spinal
deformities (<25% height loss without definite end-plate
fracture) are not strong predictors of future osteoporotic
fractures or low bone density [10]. Vertebral fractures should
be assessed visually and graded by the semiquantitative
method of Genant and should include T4-L4 vertebrae
(Table 2) [17].What Is the Role of the Radiologist in Reporting
Vertebral Fractures?Vertebral fracture recognition and reporting by radiolo-
gists was the subject of a review by OC and the CAR [14,18].
Recognizing and reporting vertebral fractures as near-certain
signs of osteoporosis are important roles that radiologists can
play in guiding physicians to reduce the risk of future oste-
oporotic fractures and close the associated care gap (Table 2)
[18,19]. Lateral radiographs or vertebral fracture assessment
(VFA) of the thoracolumbar spine to diagnose unrecognized
vertebral compression fractures assist in further stratifying
risk and clinical decision making. In a Canadian study, 1 in 6
elderly patients who had a chest radiograph was found to
have a vertebral fracture [20]. Only 60% of vertebral frac-
tures were mentioned in the radiology report [20]. The care
gap in identifying vertebral fractures on chest radiographs
has been found to be as low as 20%-50% in both national and
international studies [21].VFA with BMD MeasurementVFA is an option in which bone densitometers use fan-
beam imaging to examine the spine [2]. To date, Canadian
centres have been slow to adopt VFA technology, despite its
potential clinical value in identifying patients with previ-
ously unrecognized vertebral fractures, such as radiographic
fractures. VFA findings predict future osteoporotic and hip
fractures independently of age, weight, and BMD [18,22].
Tools to Measure 10-Year Fracture Risk
The 2010 OC Guidelines include 2 closely related tools
for estimating the 10-year risk of a major osteoporotic
fracture as defined above: an updated version of the Cana-
dian Association of Radiologists and Osteoporosis Canada
(CAROC) [23] and the Fracture Risk Assessment Tool
(FRAX) of the WHO, specific for Canada [24]. Both have
been calibrated by using the same Canadian fracture data and
have been directly validated in Canadian databases (Table 3)
[5,25,26].2010 CAROC SystemThe 2010 OC Guidelines provided an opportunity to
update CAROC [7,23] and to calibrate and validate it by
using Canadian data. The 2010 CAROC risk assessment tool
uses the patient’s age and sex, together with the femoral neck
Table 3
Comparison of the 2010 CAROC and Canadian FRAX risk assessment tools
2010 CAROC Canadian FRAX
Model Semiquantitative (low, moderate, high) Quantitative (fracture probability)
BMDa Femoral neck (required) Femoral neck (optional)
Clinical Fragility fracture; prolonged steroids Fragility fracture; prolonged steroids; body mass index; parental hip fracture;
current smoking; high alcohol use; rheumatoid arthritis; secondary causes
Output Major fracture risk Major fracture risk; hip fracture risk
High risk >20% major fracture >20% major fracture
Validation Level 1 evidence Level 1 evidence
BMD ¼ bone mineral density; CAROC ¼ Canadian Association of Radiologists and Osteoporosis Canada; FRAX ¼ Fracture Risk Assessment Tool.
aThe T score for the femoral neck is derived from the National Health and Nutrition Education Survey III reference database for white women.
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then be adjusted upward as determined by 2 major clinical
risk factors, namely fragility fractures after age 40 years
(especially vertebral compression fractures) and recent pro-
longed systemic glucocorticoid use (ie, at least 3 months
cumulative during the preceding year at a prednisone
equivalent dose of 7.5 mg daily) [27]. When both of these
clinical risk factors are present, the 10-year absolute fracture
risk is considered to be high, irrespective of the BMD result.
The method of determining absolute fracture risk
(see Table 4):
1. Begin with the table appropriate for the patient’s sex.
2. Identify the row that is closest to the patient’s age.
3. Determine the individual’s fracture risk category by
using the femoral neck T score (risk assessment by using
the updated CAROC system is based upon the femoral
neck T score only). However, when determining the risk
category, a patient with a T score of the spine, total hip,Table 4
2010 CAROC zones of fracture risk for women and men by using femoral
neck T scorea
Women
Age, y Low risk Moderate risk High risk
50 Above 2.5 2.5 to 3.8 Below 3.8
55 Above 2.5 2.5 to 3.8 Below 3.8
60 Above 2.3 2.3 to 3.7 Below 3.7
65 Above 1.9 1.9 to 3.5 Below 3.5
70 Above 1.7 1.7 to 3.2 Below 3.2
75 Above 1.2 1.2 to 2.9 Below 2.9
80 Above 0.5 0.5 to 2.6 Below 2.6
85 Above þ0.1 þ0.1 to 2.2 Below 2.2
Men
Age, y Low risk Moderate risk High risk
50 Above 2.5 2.5 to 3.9 Below 3.9
55 Above 2.5 2.5 to 3.9 Below 3.9
60 Above 2.5 2.5 to 3.7 Below 3.7
65 Above 2.4 2.4 to 3.7 Below 3.7
70 Above 2.3 2.3 to 3.7 Below 3.7
75 Above 2.3 2.3 to 3.8 Below 3.8
80 Above 2.1 2.1 to 3.8 Below 3.8
85 Above 2.0 2.0 to 3.8 Below 3.8
CAROC ¼ Canadian Association of Radiologists and Osteoporosis Canada.
aThe T score for the femoral neck is derived from the National Health and
Nutrition Education Survey III reference database for white women.or femoral neck in the osteoporotic range (ie,  2.5, at
any age) should be classified as having at least moderate
risk.
4. Evaluate clinical factors (ie, fragility fractures after age
40 years and recent prolonged systemic glucocorticoid
use) that may move the patient into a higher fracture risk
category. When both factors are present (ie, fragility
fractures and prolonged systemic glucocorticoid use), the
patient is considered to be at high fracture risk regardless
of the BMD result.Canadian FRAX SystemIn parallel with the development of the CAROC tool, OC
has worked with the WHO to develop a Canadian version of
the FRAX tool [24]. It encompasses some additional factors
(Table 3) and is country specific. Some clinical practitioners
may prefer the versatility of FRAX, which allows for risk
assessment in the absence of a BMD measurement and is
more quantitatively accurate for those patients with one of
more of the additional risk factors listed above. As well,
anyone may readily access the tool.
Some limitations to the use of the Canadian FRAX tool
are of note. First, it is computer based and requires access to
the FRAX Web site, an iPhone (Apple Inc., Cupertino, CA)
application, or specialized software on DXA (dual-emission
x-ray absorptiometry) machines (not now widely available in
Canada). Second, radiologists who use FRAX would need to
make a more complete assessment of clinical risk factors that
necessitates more detailed history taking. The clinical history
provided to radiologists by referring physicians is rarely
adequate, and, if the only patient contact involves the tech-
nologists performing DXA, then additional technologist
training must be provided to ensure accurate documentation
of the relevant clinical risk factors.
The clinical risk factors used in the CAROC model are
fewer than those used in FRAX but do capture the major
risks for fracture, and risk categorization with this tool
accurately reflects national fracture data. The updated 2010
CAROC system shows a high overall degree of concordance
in risk categorization with the Canadian FRAX tool
(approximately 90% agreement). Differences, when they
occur, usually relate to the presence of one or more risk
factors that contribute to FRAX but that are not considered in
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smoking, excess alcohol intake, rheumatoid arthritis).
The updated version of the CAROC fracture risk assess-
ment tool is easy to use and, therefore, is recommended
instead of FRAX for BMD reporting in Canada. Family
physicians, osteoporosis specialists, and those communi-
cating DXA findings are already familiar both with risk
assessment in general [28] and with the 2005 CAROC model
in particular; this should allow for a more seamless inte-
gration of the 2010 CAROC system into reporting. This
situation may change as FRAX becomes more widely used.
Addressing Other IssuesWhy Is the Lumbar Spine Not Included in the Fracture
Risk Assessment? How Do I Evaluate Risk When the
Lumbar Spine BMD Is Much Lower Than That at the
Hip?The FRAX and related 2010 CAROC risk assessment
systems were calibrated for use of femoral neck BMD based
upon: (a) the strength of the association of BMD with
subsequent fractures (particularly hip fractures), (b) repre-
sentation among the FRAX derivation cohorts, and (c)
availability of a reference standard database for BMD
normalization (NHANES III [National Health and Nutrition
Examination Survey III] white female). These risk assess-
ment models do not include lumbar spine BMD, which is
known to be strongly associated with vertebral fracture risk
[29]. Given the modest correlation between lumbar spine and
femoral neck BMD [29e33], the T scores from these 2 sites
are not uncommonly ‘‘discordant’’ [34]. Although there is no
accepted definition of discordance, it usually is described as
an absolute difference in T scores higher than 1 or 2 SDs.
The idea of using the minimum T score for major osteopo-
rotic fracture prediction is not supported by evidence from
multiple cohorts [30e33]. Substitution of the minimum T
score in the FRAX paradigm overestimates fracture proba-
bility. Simple procedures that integrate the femoral neck and
lumbar spine T scores in the assessment of major osteopo-
rotic fracture risk within the FRAX and 2010 CAROC
systems are currently in development but require further
validation before they can be recommended [34]. Mean-
while, a lumbar spine T score that is significantly worse than
the femoral neck T score is considered an additional factor
that may warrant pharmacologic treatment in those at
moderate fracture risk (Figure 1).Why Is It Recommended That Male T Scores Be
Generated by Using a Female Reference Database?In 1994, the WHO expert panel set the operational defi-
nition of osteoporosis in postmenopausal white women as
a BMD T score of 2.5 or more SDs below the normal BMD
for young healthy white women [1]. The WHO Collaborating
Centre has recently provided guidance on the diagnosis of
osteoporosis in older white and nonwhite women and men,designating BMD measurement made at the femoral neck
with DXA as the reference standard [35]. The recommended
reference range is the NHANES III reference database for
femoral neck measurements in white women aged 20-29
years by using a similar cutoff value for both men and
women (BMD T score 2.5 SD or more below the average for
young adult women). The WHO position remains contro-
versial, and other groups advocate sex-matched reference
data [36,37]. A recent report from CaMos supports the WHO
position, and, therefore, this is now the recommendation for
BMD reporting in Canada [38]. Using T scores derived from
male reference data (currently the default on DXA machines)
will slightly overestimate the fracture risk in men.What Recommendations Apply to Other Groups?For premenopausal women, children, and younger men,
the diagnosis of osteoporosis should not be made on the basis
of BMD score alone (Table 1). In these age groups, OC and
the International Society for Clinical Densitometry recom-
mend using a Z score above or below e2.0 to categorize
BMD as ‘‘within the expected range for age’’ or ‘‘below the
expected range for age’’ [33].What Is a Fragility Fracture?The most serious manifestation of osteoporosis is
a fragility fracture, defined as a fracture that occurs sponta-
neously or after minor trauma such as a fall from standing
height or less [39]. Fragility fractures (which exclude
craniofacial, hand, ankle, and foot fractures) represent 80%
of all fractures that occur in postmenopausal women aged 50
years and older. A fracture remains one of the most-
significant risk factors for predicting future fractures [12].
Forty percent of women who experience a fracture have
a history of prior fracture [40]. The risk of experiencing
another fracture in the year after a hip fracture is 5%-10% [6]
and 20% after a vertebral fracture [10].What Do I Do When Someone Has Had More Than
One Fragility Fracture?Refining the history of fracture is important in risk strat-
ification. In the CAROC and FRAX systems, fractures are
only captured as a dichotomous (yes/no) variable. However,
multiple fractures confer greater risk than a single fracture.
Individuals with more than 1 low-trauma fracture should be
regarded as at particularly high risk for future fracture [12].
Multiple vertebral fractures also confer a stronger risk for
future fractures than a single vertebral fracture.
DXA in PracticeReportingCAR recently published a standard for BMD reporting
[41]. To generate a meaningful report, the referring physician
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cation for BMD testing, factors relevant to scan assessment
(such as joint replacement, bone surgery, or bone disease in
scan regions), osteoporosis medication history, factors
crucial to fracture-risk determination (such as fragility frac-
ture history and glucocorticoid use) and other pertinent
medication information. In turn, there is a physician prefer-
ence for absolute fracture reporting [42].
All first-time BMD reports should include demographic
data, diagnostic category, fracture-risk category (if the
patient is 50 years old or older), BMD data (including BMD
in g/cm2, BMD T score, and the reference database used),
and limitations to the assessment, if any [8]. There should
follow the reporting physician’s interpretation and sugges-
tions for any follow-up, if appropriate. When reporting BMD
data, left femoral neck, total hip, and lumbar spine should be
reported. If disease or artifacts affect the interpretation of the
scan at the lumbar spine, then a forearm scan of the
nondominant arm should be done. Similarly, if the left hip
examination is compromised, then the right side can be used.
Scan date, report date, referring physician, reporting physi-
cian, facility name and location, and machine identification
(brand, model, and serial number) are other important
components of the report.
On follow-up, large changes in height and weight should
be reported. A measured prospective height loss of 2 cm or
more may suggest vertebral fracturing (most of these are
silent) and warrants further radiographic investigations
(lateral spine radiographs or VFA). Weight changes of 10%
also are prone to introduce artifact in monitoring change. In
addition, absolute (not percentage) changes in bone density
should be examined for statistical significance (when the
machine, positioning, and region of interest assignment are
consistent). This should be based upon practice and site and
DXA-machine-specific determinations of precision (g/cm2).
These data are then used for the specific determination of the
least significant change (g/cm2) and the 95% confidence
levels for statistically significant change at the different scan
sites.
Although fracture-risk prediction is valid when using
either the FRAX or 2010 CAROC models, it is recom-
mended that the reports should clearly identify the tool used
to the referring physician. With respect to therapy, neither the
FRAX nor CAROC tools reflect the risk reduction associated
with pharmacologic therapy. These tools reflect the theoret-
ical risk for a hypothetical patient who is treatment na€ıve,
that is, on treatment or having ceased a course of treatment.Quality Control and AssuranceFor a meaningful BMD result, care must be taken in
performing DXA. Quality control starts with scanning
a spine phantom daily to exclude machine drift. Preventive
maintenance of the machine should be done at least annually.
Ideally, a limited number of dedicated and educated tech-
nologists should operate each scanner to ensure consistent
results. Precision tests should be repeated whenever there arehardware or personnel changes. It should involve subjects
representative of the patient population by using protocols
that are published and available on the CAR Web site.
When scanning a patient, it is important to adhere to
manufacturer protocols regarding proper positioning, deter-
mination of regions of interest, bone mapping, and subregion
assignments. For follow-up scans, it is important that the
machine, positioning, regions of interest, bone mapping, and
subregion assignments are the same. The reproducibility of
the area in each region of interest is a guide to the consis-
tency of patient positioning between examinations. The total
proximal femur and L1-L4 lumbar spine segments combined
should be used for the determination of total lumbar spine T
score, unless there are reasons, degenerative disease or arti-
facts, to exclude up to 2 vertebrae (a T score at least 1 SD
different from the supra- or subadjacent vertebrae should
prompt but not mandate examining the image and other
evidence to decide if a segment needs to be excluded).
Summary
The 2010 OC Guidelines integrate 10-year absolute
fracture risk prediction into an overall management approach
by using validated risk assessment tools. There currently is
a large gap between the optimal practices and treatments that
are currently being provided to Canadians with osteoporosis.
These guidelines are part of a concerted effort to close this.
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